These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28415011)

  • 1. Design and synthesis of novel xanthine derivatives as potent and selective A
    Basu S; Barawkar DA; Ramdas V; Patel M; Waman Y; Panmand A; Kumar S; Thorat S; Naykodi M; Goswami A; Reddy BS; Prasad V; Chaturvedi S; Quraishi A; Menon S; Paliwal S; Kulkarni A; Karande V; Ghosh I; Mustafa S; De S; Jain V; Banerjee ER; Rouduri SR; Palle VP; Chugh A; Mookhtiar KA
    Eur J Med Chem; 2017 Jul; 134():218-229. PubMed ID: 28415011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A
    Basu S; Barawkar DA; Ramdas V; Waman Y; Patel M; Panmand A; Kumar S; Thorat S; Bonagiri R; Jadhav D; Mukhopadhyay P; Prasad V; Reddy BS; Goswami A; Chaturvedi S; Menon S; Quraishi A; Ghosh I; Dusange S; Paliwal S; Kulkarni A; Karande V; Thakre R; Bedse G; Rouduri S; Gundu J; Palle VP; Chugh A; Mookhtiar KA
    Eur J Med Chem; 2017 Feb; 127():986-996. PubMed ID: 27842891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
    Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
    J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the structural determinants of novel xanthine derivatives as A
    Yang Y; Li Y; Zhou W; Chen Y; Wu Q; Pan Y; Zhang S; Yang L
    J Biomol Struct Dyn; 2019 Aug; 37(13):3467-3481. PubMed ID: 30175951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Substituted-7-N-alkyl-N-acetyl 2-aminobenzothiazole amides: drug-like and non-xanthine based A2B adenosine receptor antagonists.
    Cheung AW; Brinkman J; Firooznia F; Flohr A; Grimsby J; Gubler ML; Guertin K; Hamid R; Marcopulos N; Norcross RD; Qi L; Ramsey G; Tan J; Wen Y; Sarabu R
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4140-6. PubMed ID: 20541935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel quinolinone adenosine A2B antagonists.
    McGuinness BF; Ho KK; Stauffer TM; Rokosz LL; Mannava N; Kultgen SG; Saionz K; Klon A; Chen W; Desai H; Rogers WL; Webb M; Yin J; Jiang Y; Li T; Yan H; Jing K; Zhang S; Majumdar KK; Srivastava V; Saha S
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7414-20. PubMed ID: 21055932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A
    Jiang J; Seel CJ; Temirak A; Namasivayam V; Arridu A; Schabikowski J; Baqi Y; Hinz S; Hockemeyer J; Müller CE
    J Med Chem; 2019 Apr; 62(8):4032-4055. PubMed ID: 30835463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists.
    Elzein E; Kalla R; Li X; Perry T; Parkhill E; Palle V; Varkhedkar V; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J
    Bioorg Med Chem Lett; 2006 Jan; 16(2):302-6. PubMed ID: 16275090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists.
    Baraldi PG; Baraldi S; Saponaro G; Preti D; Romagnoli R; Piccagli L; Cavalli A; Recanatini M; Moorman AR; Zaid AN; Varani K; Borea PA; Tabrizi MA
    J Med Chem; 2012 Jan; 55(2):797-811. PubMed ID: 22148859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trifluorinated Pyrimidine-Based A
    Mallo-Abreu A; Majellaro M; Jespers W; Azuaje J; Caamaño O; García-Mera X; Brea JM; Loza MI; Gutiérrez-de-Terán H; Sotelo E
    J Med Chem; 2019 Oct; 62(20):9315-9330. PubMed ID: 31557025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.
    El Maatougui A; Azuaje J; González-Gómez M; Miguez G; Crespo A; Carbajales C; Escalante L; García-Mera X; Gutiérrez-de-Terán H; Sotelo E
    J Med Chem; 2016 Mar; 59(5):1967-83. PubMed ID: 26824742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-affinity relationships of adenosine A2B receptor ligands.
    Beukers MW; Meurs I; Ijzerman AP
    Med Res Rev; 2006 Sep; 26(5):667-98. PubMed ID: 16847822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseases.
    Elzein E; Kalla RV; Li X; Perry T; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J
    J Med Chem; 2008 Apr; 51(7):2267-78. PubMed ID: 18321039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
    Stefanachi A; Nicolotti O; Leonetti F; Cellamare S; Campagna F; Loza MI; Brea JM; Mazza F; Gavuzzo E; Carotti A
    Bioorg Med Chem; 2008 Nov; 16(22):9780-9. PubMed ID: 18938084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
    Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
    Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A
    Basu S; Barawkar DA; Thorat S; Shejul YD; Patel M; Naykodi M; Jain V; Salve Y; Prasad V; Chaudhary S; Ghosh I; Bhat G; Quraishi A; Patil H; Ansari S; Menon S; Unadkat V; Thakare R; Seervi MS; Meru AV; De S; Bhamidipati RK; Rouduri SR; Palle VP; Chug A; Mookhtiar KA
    J Med Chem; 2017 Jan; 60(2):681-694. PubMed ID: 28055204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible Antagonists for the Adenosine A
    Temirak A; Schlegel JG; Voss JH; Vaaßen VJ; Vielmuth C; Claff T; Müller CE
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A
    Squarcialupi L; Betti M; Catarzi D; Varano F; Falsini M; Ravani A; Pasquini S; Vincenzi F; Salmaso V; Sturlese M; Varani K; Moro S; Colotta V
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):248-263. PubMed ID: 28114825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonists of the adenosine A
    Duroux R; Agouridas L; Renault N; El Bakali J; Furman C; Melnyk P; Yous S
    Eur J Med Chem; 2018 Jan; 144():151-163. PubMed ID: 29268131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.